Clinical Trial Update: Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer [NA]

View source ↗

Summary

This clinical trial update describes an oral immunomodulatory nutrient being studied for survival during postoperative concomitant chemoradiotherapy in head and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Oral Immunomodulatory Nutrient

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: Head and Neck Squamous Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING